Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit)

v3.23.3
Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2021   114,452,000    
Balance at beginning of period at Dec. 31, 2021 $ 179,620 $ 11 $ 650,518 $ (470,909)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 10,862   10,862  
Issuance of common stock upon exercise of stock options (in shares)   404,000    
Issuance of common stock upon exercise of stock options 17   17  
Issuance of common stock upon vesting of restricted stock awards (in shares)   129,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   4,816,000    
Stock Issued During Period, Value, Restricted Stock Units, Net of Forfeitures 1 $ 1    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)   1,874,000    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (3,616)   (3,616)  
Net loss (19,992)     (19,992)
Balance at end of period (in shares) at Mar. 31, 2022   117,927,000    
Balance at end of period at Mar. 31, 2022 166,892 $ 12 657,781 (490,901)
Balance at beginning of period (in shares) at Dec. 31, 2021   114,452,000    
Balance at beginning of period at Dec. 31, 2021 179,620 $ 11 650,518 (470,909)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Repurchase and retirement of common stock 30      
Net loss (59,367)      
Balance at end of period (in shares) at Sep. 30, 2022   118,906,000    
Balance at end of period at Sep. 30, 2022 133,360 $ 12 663,654 (530,306)
Balance at beginning of period (in shares) at Mar. 31, 2022   117,927,000    
Balance at beginning of period at Mar. 31, 2022 166,892 $ 12 657,781 (490,901)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 3,365   3,365  
Issuance of common stock upon exercise of stock options (in shares)   180,000    
Issuance of common stock upon exercise of stock options 8   8  
Issuance of common stock upon vesting of restricted stock awards (in shares)   27,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   520,000    
Stock Issued During Period, Value, Restricted Stock Units, Net of Forfeitures 0 $ 0    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)   201,000    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (444)   (444)  
Net loss (26,282)     (26,282)
Balance at end of period (in shares) at Jun. 30, 2022   118,453,000    
Balance at end of period at Jun. 30, 2022 143,539 $ 12 660,710 (517,183)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 3,423   3,423  
Issuance of common stock upon exercise of stock options (in shares)   54,000    
Issuance of common stock upon exercise of stock options 12   12  
Issuance of common stock upon vesting of restricted stock awards (in shares)   22,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   633,000    
Stock Issued During Period, Value, Restricted Stock Units, Net of Forfeitures 0      
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)   241,000    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (491)   (491)  
Repurchase and retirement of common stock (in shares)   (15,000)    
Repurchase and retirement of common stock (30)     (30)
Net loss (13,093)     (13,093)
Balance at end of period (in shares) at Sep. 30, 2022   118,906,000    
Balance at end of period at Sep. 30, 2022 $ 133,360 $ 12 663,654 (530,306)
Balance at beginning of period (in shares) at Dec. 31, 2022 119,508,000 119,508,000    
Balance at beginning of period at Dec. 31, 2022 $ 121,874 $ 12 666,973 (545,111)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 3,214   3,214  
Issuance of common stock upon exercise of stock options (in shares)   129,000    
Issuance of common stock upon exercise of stock options 3   3  
Issuance of common stock upon vesting of restricted stock awards (in shares)   11,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   787,000    
Stock Issued During Period, Value, Restricted Stock Units, Net of Forfeitures 0 $ 0    
Issuance of common stock (in shares)   16,404,000    
Issuance of common stock 11,129 $ 2 11,127  
Net loss (17,315)     (17,315)
Balance at end of period (in shares) at Mar. 31, 2023   136,839,000    
Balance at end of period at Mar. 31, 2023 $ 118,905 $ 14 681,317 (562,426)
Balance at beginning of period (in shares) at Dec. 31, 2022 119,508,000 119,508,000    
Balance at beginning of period at Dec. 31, 2022 $ 121,874 $ 12 666,973 (545,111)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Repurchase and retirement of common stock 0      
Net loss $ (50,071)      
Balance at end of period (in shares) at Sep. 30, 2023 140,543,000 140,543,000    
Balance at end of period at Sep. 30, 2023 $ 92,135 $ 14 687,303 (595,182)
Balance at beginning of period (in shares) at Mar. 31, 2023   136,839,000    
Balance at beginning of period at Mar. 31, 2023 118,905 $ 14 681,317 (562,426)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 2,488   2,488  
Issuance of common stock upon exercise of stock options (in shares)   95,000    
Issuance of common stock upon exercise of stock options 2   2  
Issuance of common stock upon vesting of restricted stock awards (in shares)   8,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   668,000    
Issuance of common stock (in shares)   1,039,000    
Issuance of common stock 995   995  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)   240,000    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (414)   (414)  
Net loss (33,431)     (33,431)
Balance at end of period (in shares) at Jun. 30, 2023   138,409,000    
Balance at end of period at Jun. 30, 2023 88,545 $ 14 684,388 (595,857)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock upon vesting of restricted stock awards (in shares) 2,562   2,562  
Issuance of common stock upon exercise of stock options (in shares)   98,000    
Issuance of common stock upon exercise of stock options 4   4  
Issuance of common stock upon vesting of restricted stock awards (in shares)   8,000    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,664,000    
Issuance of common stock (in shares)   804,000    
Issuance of common stock 908   908  
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)   440,000    
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (559)   (559)  
Net loss $ 675     675
Balance at end of period (in shares) at Sep. 30, 2023 140,543,000 140,543,000    
Balance at end of period at Sep. 30, 2023 $ 92,135 $ 14 $ 687,303 $ (595,182)